[1]Chinese Pharmacopoeia Commission.Phatmacopoeia of the people`s pepublic of China.Volum Ⅰ[M]. Beijing:People`s Medical Publishing House,2010:11-12. [2]Ng TB. Pharmacological activity of sanchi ginseng (Panax notoginseng)[J].J Pharm Pharmacol,2006,58(8):1007-1019. [3]杨志刚,陈阿琴,俞颂东.三七药理研究新进展[J].上海中医药杂志,2005,39(4):59-62. [4]李敬常,周伟贞,叶丽明.三七水提物对动物乙醇损伤的保护作用[J].中成药,1992,14(8):32-33. [5]黎光南,周志华,章观德.熟三七粉补血成分的研究[J].中成药研究,1982(12):31-33. [6]鲁海燕,何永恒.花椒、延胡索、没药、三七四味中药止痛作用的药理学研究进展[J].亚太传统医药,2009,2:60-62. [7]韩刚,孙辉业,董延生,等.三七总皂苷对大鼠肝脏肾脏的毒性作用[J].中国新药杂志,2006,15(24):2115-2118. [8]马玉奎、戴晓莉.三七总皂苷安全性的实验研究[J].食品与药品,2011,13(11):408-411. [9]国家技术监督局.GB 15193.3—2003 食品安全性毒理学评价程序[S].北京:中国标准出版社,2003:19-88. [10]Klaassen D. Toxicology: the basic science of poisons[M].6th edition.New York:McGraw-Hill Professional, 2002:419-420. [11]Ji W,Gong BQ.Hypolipidemic effects and mechanisms of Panax notoginseng on lipid profile in hyperlipidemic rats[J].J Ethnopharmacol,2007,113(2):318-324. [12]Zhang JH,Wang JP, Wang HJ. Clinical study on effect of total panax notoginseng saponins on immune related inner environment imbalance in rheumatoid arthritis patients[J].Zhong Guo Zhong Xi Yi Jie He Za Zhi,2007,27(7):183-191. [13]Li J,Xie ZZ,Tang YB,et al.Ginsenoside-Rd, a purified component from panax notoginseng saponins, prevents atherosclerosis in apoE knockout mice[J].Eur J Pharmacol,2011,652(1-3):104-110. [14]Yan Z,Zhu ZL,Wang HQ,et al.Pharmacokinetics of panaxatrol disuccinate sodium, a novel anti-cancer drug from Panax notoginseng, in healthy volunteers and patients with advanced solid tumors[J].Acta Pharmacol Sin,2010,31(11):1515-1522. [15]谭毓治.药物毒理学[M].北京:科学出版社,2010:96-97. |